SlidesetHIVINTEREST 2016HIV Testing Strategies: How to Reach 90% Knowledge of Serostatus (including the role of self-testing) | Elizabeth MarumView Slideset
SlidesetHIVINTEREST 2016The Joep Lange Institute / Art and Science in the HIV response | Brandon O’DellView Slideset
SlidesetHIVINTEREST 2016Progress in HIV Prevention and Treatment Scale-Up in Sub-Saharan Africa | Claire MulangaView Slideset
SlidesetHIVINTEREST 2016Ebola to Lassa Fever: Leassons learnt | Ismail Adeshina Abdus-SalamView Slideset
SlidesetHIVINTEREST 2016Lessons learnt About the Ethics of Trial Conduct in Emergency Settings | Morenike Ukpong FolayanView Slideset
SlidesetHIVINTEREST 2016Lessons learnt About Good Participatory Practices in Prevention and Treatment Trials for HIV and for Emerging Pathogens | Lillian MutenguView Slideset
SlidesetHIVINTEREST 2016Lessons learnt from Ebola Therapeutic Trials and Survivor Cohort Studies | Daouda Sissoko, MDView Slideset
SlidesetHIVINTEREST 2016Progress on viral load monitoring, laboratory quality assurance, point of care | John Nkengasong, PhDView Slideset
SlidesetHIVINTEREST 2016Acquired Drug Resistance: Causes, Patterns, and Implications for SSA | Coumba Toure Kane, PharmD, PhDView Slideset
NPNicholas PatonMD, FRCPSlidesetHIVINTEREST 2016Evolving Treatment Paradigms: Relevance in Resource- Limited Settings | Nicholas Paton, MD, FRCPView Slideset
